Literature DB >> 18216531

Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment.

Sung-Hsin Kuo1, Li-Tzong Chen, Ming-Shiang Wu, Chung-Wu Lin, Kun-Huei Yeh, Kuan-Ting Kuo, Pei-Yen Yeh, Yi-Shin Tzeng, Hsiu-Po Wang, Ping-Ning Hsu, Jaw-Town Lin, Ann-Lii Cheng.   

Abstract

BACKGROUND: Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is characterized by multifocality of the tumors, which often scatter over the mucosa of the stomach and adjacent upper gastrointestinal tract, and is therefore theoretically not curable by surgical resection.
METHODS: We conducted a long-term follow-up study of 14 patients who received surgical treatment for gastric MALT lymphoma. Tissues from the surgical margins of the resected stomach were analyzed by polymerase chain reaction-based amplification of the complementarity-determining region 3 of the IgH gene for the presence of residual tumors. T (11;18)(q21;q21), a marker of Helicobacter pylori-independent MALT lymphoma, was analyzed by reverse transcription polymerase chain reaction. All living patients were restaged, and rebiopsied if suspicious lesions were identified.
RESULTS: At a median follow-up of 11.5 years, only 1 patient had evidence of tumor recurrence. Three patients with molecularly proven residual tumors in the surgical margin remained disease-free at 9.6 to 11.6 years. Five patients with t(11;18)(q21;q21) in the tumor cells were disease-free at 9.2 to 12.6 years.
CONCLUSION: Our results indicate that surgical resection is a highly curative treatment for gastric MALT lymphoma, even for patients with residual tumor cells in the surgical margins, and for patients with H. pylori-independent tumors. A revisit of surgical treatment for gastric MALT lymphoma is mandatory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216531     DOI: 10.1097/SLA.0b013e3181582364

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Authors:  Hidekazu Suzuki; Yoshimasa Saito; Toshifumi Hibi
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

2.  Gastric MALT lymphoma and grade II obesity: gastric bypass surgery as a therapeutic option.

Authors:  Ricardo Helman; Priscila Pereira dos Santos Teixeira; Carlos José Lazzarini Mendes; Thomas Szegö; Nelson Hamerschlak; Nelson Hamershlak
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

Review 3.  Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Jeong Bae Park; Ja Seol Koo
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 4.  Helicobacter and gastric malignancies.

Authors:  António Carlos Ferreira; Hajime Isomoto; Masatsugu Moriyama; Toshio Fujioka; José Carlos Machado; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

5.  Molecular Aspects of H. pylori-Related MALT Lymphoma.

Authors:  Scott R Owens; Lauren B Smith
Journal:  Patholog Res Int       Date:  2011-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.